Abstract
Among neurodegenerative diseases, Alzheimer disease (AD) is a leading cause of death in elderly individuals. AD is characterized, among other clinical findings, by unexplained weight loss, cachexia and altered immune function. Alteration in energy balance and nutritional status are relayed to the feeding-related hypothalamic nuclei by neuronal pathways and/or via alterations in the levels of eating-controlling hormones. The adipocyte-derived hormone, leptin, and the pancreatic-derived peptide, insulin, function as hormonal signaling mechanisms for fat deposition and play a key role in regulating food intake, body weight and energy homeostasis via their actions on specific hypothalamic nuclei. Moreover, leptin, insulin and their receptors are widely expressed in many hypothalamic and extra-hypothalamic brain regions indicating that these hormones may have other neuronal functions. Although emerging evidence supports the role of insulin resistance in the development of AD, the potential involvement of leptin in the pathogenic process of AD has been proposed only recently. Here we review recent reports and progress concerning the molecular mechanism and the potential role of leptin and insulin in AD.
Keywords: Leptin, insulin, signal transduction, Alzheimer disease, review
Central Nervous System Agents in Medicinal Chemistry
Title: Alzheimer Disease: What Role for Leptin and Insulin?
Volume: 6 Issue: 4
Author(s): Sami Dridi, D. Dominguez and J. Buyse
Affiliation:
Keywords: Leptin, insulin, signal transduction, Alzheimer disease, review
Abstract: Among neurodegenerative diseases, Alzheimer disease (AD) is a leading cause of death in elderly individuals. AD is characterized, among other clinical findings, by unexplained weight loss, cachexia and altered immune function. Alteration in energy balance and nutritional status are relayed to the feeding-related hypothalamic nuclei by neuronal pathways and/or via alterations in the levels of eating-controlling hormones. The adipocyte-derived hormone, leptin, and the pancreatic-derived peptide, insulin, function as hormonal signaling mechanisms for fat deposition and play a key role in regulating food intake, body weight and energy homeostasis via their actions on specific hypothalamic nuclei. Moreover, leptin, insulin and their receptors are widely expressed in many hypothalamic and extra-hypothalamic brain regions indicating that these hormones may have other neuronal functions. Although emerging evidence supports the role of insulin resistance in the development of AD, the potential involvement of leptin in the pathogenic process of AD has been proposed only recently. Here we review recent reports and progress concerning the molecular mechanism and the potential role of leptin and insulin in AD.
Export Options
About this article
Cite this article as:
Dridi Sami, Dominguez D. and Buyse J., Alzheimer Disease: What Role for Leptin and Insulin?, Central Nervous System Agents in Medicinal Chemistry 2006; 6 (4) . https://dx.doi.org/10.2174/187152406779010877
DOI https://dx.doi.org/10.2174/187152406779010877 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Current Genomics Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications
Current Medicinal Chemistry Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments
Current Drug Targets Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
Current Medicinal Chemistry RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point
Anti-Cancer Agents in Medicinal Chemistry Recent Developments of Flavonoids with Various Activities
Current Topics in Medicinal Chemistry MET and ALK as Targets for the Treatment of NSCLC
Current Pharmaceutical Design Synthesis, Biological Activity of Thiazolidinones Bearing Indoline Moiety and Isatin Based Hybrids
Mini-Reviews in Organic Chemistry Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects
Current Stem Cell Research & Therapy The Chemistry and Pharmacology of Genistein
The Natural Products Journal Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy
Current Medicinal Chemistry The Polyhedric Abl Kinases and their Pharmacologic Inhibitors
Current Enzyme Inhibition Glucose Oncometabolism of Esophageal Cancer
Anti-Cancer Agents in Medicinal Chemistry The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Current Drug Targets Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists
Current Pharmaceutical Design Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences
Current Gene Therapy Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design Role of ncRNAs in Development, Diagnosis and Treatment of Human Cancer
Recent Patents on Anti-Cancer Drug Discovery Phenolic Compounds as Nutraceuticals or Functional Food Ingredients
Current Pharmaceutical Design Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson’s Disease
Mini-Reviews in Medicinal Chemistry